Evaluation of the expression of NADPH oxidase components during maturation of HL-60 cells to neutrophil lineage

被引:0
|
作者
Hua, J
Hasebe, T
Someya, A
Nakamura, S
Sugimoto, K
Nagaoka, I
机构
[1] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan
[2] Juntendo Univ, Sch Med, Dept Med, Div Hematol,Bunkyo Ku, Tokyo 1138421, Japan
[3] Juntendo Univ, Sch Med, Div Pathol, Bunkyo Ku, Tokyo 1138421, Japan
关键词
superoxide; cytochrome b(558); cytosolic factor;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To understand the expression of NADPH oxidase components during neutrophil maturation, we examined the expression of mRNAs and proteins for NADPH oxidase components, and the superoxide-producing activity using HL-60 cells incubated with dimethyl sulfoxide (DMSO). Northern blot and Western blot analyses revealed that gp91(phox), P67(phox), and p47(phox) were expressed after myelocyte stages, whereas p22(phox), p40(phox), and rac-2 were expressed from the pro-myelocyte stage. Furthermore, immunocytochemical staining of DMSO-induced HL-60 cells indicated that g-p91(phox), p67(phox), and p47(phox) were detected only after myelocyte stages (myelocytes, metamyelocytes, band cells, and segmented cells), whereas p22(phox), p40(phox), and rac-2 were detected from the promyelocyte stage. In addition, nitro blue tetrazolium (NBT) assay showed that superoxide could be produced after myelocyte stages but not produced before promyelocyte stages. Moreover, almost the same results as those with DMSO-induced HL-60 cells were obtained using human bone-marrow cells by immunocytochemical staining and NET assay, except that p22(phox) was detected by immunocytochemical staining after myelocyte stages in bone-marrow cells. Together, these observations indicate that all the components for NADPH oxidase are expressed, and the superoxide-producing activity is obtained after myelocyte stages during neutrophil maturation.
引用
收藏
页码:216 / 224
页数:9
相关论文
共 50 条
  • [1] Evaluation of the expression of NADPH oxidase components during maturation of HL-60 clone 15 cells to eosinophilic lineage
    J. Hua
    T. Hasebe
    A. Someya
    S. Nakamura
    K. Sugimoto
    I. Nagaoka
    Inflammation Research, 2001, 50 : 156 - 167
  • [2] Evaluation of the expression of NADPH oxidase components during maturation of HL-60 clone 15 cells to eosinophilic lineage
    Hua, J
    Hasebe, T
    Someya, A
    Nakamura, S
    Sugimoto, K
    Nagaoka, I
    INFLAMMATION RESEARCH, 2001, 50 (03) : 156 - 167
  • [3] ANALYSIS OF THE NADPH OXIDASE COMPONENTS DURING DIFFERENTIATION OF HL-60 CELLS TO EOSINOPHILIC LINEAGE
    MIYAMOTO, D
    SOMEYA, A
    NUNOI, H
    NAGAOKA, I
    YAMASHITA, T
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1994, 1224 (01): : 11 - 16
  • [4] DIFFERENTIAL EXPRESSION OF CYTOSOLIC ACTIVATION FACTORS FOR NADPH OXIDASE IN HL-60 CELLS
    JUNGBLUT, P
    SEIFERT, R
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1988, 369 (09): : 845 - 845
  • [5] Effects of Anaplasma phagocytophila on NADPH oxidase components in human neutrophils and HL-60 cells
    Mott, J
    Rikihisa, Y
    Tsunawaki, S
    INFECTION AND IMMUNITY, 2002, 70 (03) : 1359 - 1366
  • [6] DIFFERENTIAL EXPRESSION OF CYTOSOLIC ACTIVATION FACTORS FOR NADPH OXIDASE IN HL-60 LEUKEMIC-CELLS
    SEIFERT, R
    JUNGBLUT, P
    SCHULTZ, G
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (03) : 1109 - 1117
  • [7] A PERMEABILIZED CELL PREPARATION FOR STUDY OF NADPH OXIDASE ACTIVATION IN HL-60 CELLS
    BAYER, CR
    HADJOKAS, NE
    NIELSON, CP
    FASEB JOURNAL, 1992, 6 (05): : A1612 - A1612
  • [8] REVERSIBLE ACTIVATION OF NADPH OXIDASE IN MEMBRANES OF HL-60 HUMAN-LEUKEMIC CELLS
    SEIFERT, R
    SCHULTZ, G
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 146 (03) : 1296 - 1302
  • [9] PROTEIN EXPRESSION AND DEVELOPMENT OF OXIDASE PRIMING IN MATURING HL-60 CELLS
    LLOYDS, D
    HALLETT, MB
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1994, 22 (03) : S326 - S326
  • [10] CHARACTERIZATION OF MYC PROTO-ONCOGENE EXPRESSION DURING INDUCED MATURATION OF HL-60 CELLS
    HIGH, KA
    SCHNEIDER, JW
    HU, W
    ELWELL, J
    BENZ, EJ
    CLINICAL RESEARCH, 1984, 32 (02): : A526 - A526